Patrick Glassman

Assistant Professor

Temple University

United States

Research Interests

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Patrick Glassman is an Assistant Professor at Temple University in the United States. His research focuses on biotherapeutic delivery systems, particularly the use of red blood cells as natural carriers for drug delivery and the modulation of cardiac function through RNA therapies. Recent publications include studies on extending the efficacy of biotherapeutics and developing novel nanocarrier systems for targeted treatment applications.

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Jacob S. Brenner

University of Pennsylvania

UNITED STATES

View details

Victor Ferrari

Professor of Medicine and Radiology

Hospital of the University of Pennsylvania

UNITED STATES

View details

Colin Greineder

Assistant Professor

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick Glassman

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo.

Biomechanical and Functional Features of the Carrier Erythrocytes Prolonging Circulation Time of Biotherapeutic Targeted to Glycophorin A

Development of a predictive algorithm for the efficacy of half-life extension strategies

Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain

Effective Prevention of Arterial Thrombosis with Albumin-Thrombin Inhibitor Conjugates

Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation

Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers

Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery

Target-mediated exposure enhancement: a previously unexplored limit of TMDD

Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier.

Collaborators (3)

Jacob S. Brenner

Victor Ferrari

Colin Greineder

Make your next move.